Key Enzymes in Metabolism

Why This Matters

Metabolism isn't just a list of reactions to memorize. It's an integrated network where enzymes act as gatekeepers, deciding when to store energy, when to burn it, and when to build new molecules. You're being tested on your understanding of enzyme regulation, pathway integration, and metabolic logic. Why does the cell activate one enzyme while inhibiting another? How do opposing pathways like glycolysis and gluconeogenesis avoid running simultaneously? These are the questions that show up on exams.

The enzymes in this guide demonstrate core biochemical principles: allosteric regulation, feedback inhibition, feedforward activation, and hormonal control. Each enzyme isn't just a catalyst; it's a decision point where the cell responds to its energy status, substrate availability, and hormonal signals. Don't just memorize what each enzyme does. Know why it's regulated the way it is and how it connects to the bigger metabolic picture.

---

Glycolysis: Controlling Glucose Breakdown

Glycolysis converts glucose to pyruvate, generating a net 2 ATP and 2 NADH per glucose. The pathway is regulated at three irreversible steps, each catalyzed by an enzyme that responds to the cell's energy charge. When ATP is abundant, glycolysis slows; when AMP accumulates, it accelerates.

Hexokinase

• Traps glucose inside cells by phosphorylating glucose to glucose-6-phosphate (G6P), committing it to intracellular metabolism
• Product inhibition by G6P prevents excessive glucose phosphorylation when downstream pathways are saturated
• Low $K_m$ for glucose (~0.1 mM) means it works efficiently even at low glucose concentrations, ensuring most tissues capture available fuel

Note that the liver uses glucokinase instead, which has a much higher $K_m$ (~10 mM). Glucokinase acts as a glucose sensor: it only ramps up activity when blood glucose is high (after a meal), allowing the liver to buffer postprandial glucose spikes. Glucokinase is not inhibited by G6P but is regulated by a glucokinase regulatory protein.

Phosphofructokinase-1 (PFK-1)

• Rate-limiting enzyme of glycolysis that converts fructose-6-phosphate to fructose-1,6-bisphosphate (F1,6BP), the committed step
• Allosteric activation by AMP and fructose-2,6-bisphosphate (F2,6BP) signals low energy status and the fed state, respectively
• Inhibited by ATP and citrate: high energy charge and abundant TCA cycle intermediates slow glycolysis

F2,6BP deserves special attention. It's produced by PFK-2/FBPase-2, a bifunctional enzyme controlled by insulin and glucagon. In the fed state, insulin activates the PFK-2 kinase domain, raising F2,6BP and stimulating glycolysis. During fasting, glucagon (via PKA phosphorylation) activates the FBPase-2 phosphatase domain, lowering F2,6BP and slowing glycolysis. This is how hormonal signals reach PFK-1 indirectly.

Pyruvate Kinase

• Final ATP-generating step that converts phosphoenolpyruvate (PEP) to pyruvate with substrate-level phosphorylation
• Feedforward activation by F1,6BP coordinates the enzyme with upstream flux through PFK-1
• Inhibited by ATP and alanine: alanine signals that amino acid pools are full and gluconeogenic precursors are available
• The liver isoform (L-type) is also inactivated by glucagon-driven phosphorylation, which helps redirect PEP toward gluconeogenesis during fasting

---

The Citric Acid Cycle: Energy Sensing at the Core

The citric acid cycle (TCA cycle) oxidizes acetyl-CoA to $CO_2$, generating NADH and $FADH_2$ that feed the electron transport chain. Regulation occurs at three irreversible steps, all sensitive to the NADH/NAD⁺ ratio and energy status.

Citrate Synthase

• Gateway to the TCA cycle that condenses acetyl-CoA and oxaloacetate (OAA) to form citrate
• Substrate availability is the primary regulator: the reaction depends on both acetyl-CoA and OAA concentrations. It's also inhibited by ATP, NADH, and succinyl-CoA.
• Links carbohydrate and fat metabolism since acetyl-CoA from glycolysis (via pyruvate dehydrogenase) and from β-oxidation both enter here

Isocitrate Dehydrogenase

• First oxidative decarboxylation that converts isocitrate to α-ketoglutarate, releasing $CO_2$ and producing NADH
• Activated by ADP and $Ca^{2+}$; inhibited by ATP and NADH, making it highly sensitive to energy charge
• Often considered the rate-limiting step of the TCA cycle because of how tightly it responds to the ATP/ADP and NADH/NAD⁺ ratios

α-Ketoglutarate Dehydrogenase

• Second oxidative decarboxylation that produces succinyl-CoA, $CO_2$, and NADH
• Structurally and mechanistically similar to the pyruvate dehydrogenase complex (both are multi-enzyme complexes requiring the same five coenzymes: TPP, lipoamide, CoA, FAD, NAD⁺)
• Product inhibition by succinyl-CoA and NADH prevents cycle overload
• Connects to amino acid metabolism since α-ketoglutarate is a key nitrogen carrier (via transamination) and biosynthetic precursor

---

Gluconeogenesis: Making Glucose When You Need It

Gluconeogenesis synthesizes glucose from non-carbohydrate precursors (lactate, glycerol, glucogenic amino acids), primarily in the liver. It bypasses the three irreversible steps of glycolysis using different enzymes, ensuring the two pathways don't run simultaneously.

The four bypass enzymes are: pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. Two of the most commonly tested are below.

Phosphoenolpyruvate Carboxykinase (PEPCK)

• Bypasses pyruvate kinase by converting oxaloacetate to phosphoenolpyruvate (PEP), consuming GTP
• This reaction works in tandem with pyruvate carboxylase, which first converts pyruvate to OAA (requiring biotin and ATP). Together, these two enzymes accomplish the energetically unfavorable reversal of the pyruvate kinase step.
• Transcriptionally induced by glucagon (via CREB) and cortisol during fasting; repressed by insulin
• Rate-limiting for gluconeogenesis: its expression level largely determines gluconeogenic capacity

Glucose-6-Phosphatase

• Releases free glucose into the blood by hydrolyzing G6P to glucose, the final step of gluconeogenesis (and glycogenolysis)
• Found only in liver and kidney: muscle lacks this enzyme, which is why muscle glycogen can't contribute to blood glucose directly. Muscle instead releases lactate (Cori cycle) or alanine (glucose-alanine cycle) for the liver to use.
• Located in the ER membrane: G6P must be transported into the ER lumen for hydrolysis, and free glucose is then exported

---

Glycogen Metabolism: Rapid Energy Storage and Release

Glycogen serves as a glucose reserve in liver (for blood glucose maintenance) and muscle (for local fuel during contraction). Synthesis and breakdown are reciprocally regulated by hormones, ensuring the cell never builds and degrades glycogen simultaneously.

Glycogen Synthase

• Builds glycogen by adding UDP-glucose units to growing glycogen chains via α-1,4 glycosidic bonds
• Activated by insulin (which stimulates protein phosphatase 1 to dephosphorylate the enzyme) and allosterically by G6P
• Inhibited by phosphorylation via GSK-3 and other kinases downstream of glucagon/epinephrine signaling: fasting hormones shut down synthesis

Glycogen Phosphorylase

• Mobilizes glycogen by cleaving α-1,4 bonds to release glucose-1-phosphate (not free glucose)
• Activated by phosphorylation (glucagon in liver, epinephrine in muscle via the cAMP → PKA → phosphorylase kinase cascade): opposite regulation from glycogen synthase
• Allosterically activated by AMP (in the muscle isoform) and inhibited by ATP and G6P, so it responds to local energy needs independent of hormonal signals

---

Fatty Acid Metabolism: Synthesis vs. Oxidation

Fatty acid synthesis occurs in the cytosol, while β-oxidation occurs in the mitochondrial matrix. They are reciprocally regulated so the cell doesn't build and break down fatty acids at the same time. Malonyl-CoA is the key metabolite that prevents simultaneous synthesis and degradation.

Acetyl-CoA Carboxylase (ACC)

• Committed step of fatty acid synthesis that carboxylates acetyl-CoA to malonyl-CoA, using biotin as a cofactor and consuming ATP
• Activated by citrate (signals abundant acetyl-CoA from the TCA cycle); inhibited by palmitoyl-CoA (end-product feedback)
• Phosphorylation by AMPK inactivates ACC when cellular energy is low, blocking fat synthesis and allowing β-oxidation to proceed

Fatty Acid Synthase (FAS)

• Large multi-enzyme complex (a homodimer with seven catalytic activities) that synthesizes palmitate (16:0) from acetyl-CoA and malonyl-CoA through repeated cycles of condensation, reduction, dehydration, and reduction
• Requires NADPH as the reducing agent, linking fatty acid synthesis to the pentose phosphate pathway and the malic enzyme reaction
• Induced by insulin in the fed state; regulated primarily at the transcriptional level (via SREBP-1c)

Carnitine Palmitoyltransferase I (CPT-I)

• Controls fatty acid entry into mitochondria by transferring long-chain acyl groups from CoA to carnitine for transport across the inner mitochondrial membrane
• Inhibited by malonyl-CoA: this is the mechanism preventing simultaneous synthesis and oxidation
• Rate-limiting for β-oxidation: when malonyl-CoA drops during fasting (because AMPK phosphorylates and inactivates ACC), CPT-I becomes active and fatty acid oxidation accelerates

---

Nitrogen Metabolism: Handling Ammonia

Amino acid catabolism generates toxic ammonia ($NH_3$/$NH_4^+$) that must be safely processed. The urea cycle in the liver converts ammonia to urea for excretion by the kidneys, while glutamine serves as a non-toxic nitrogen carrier in peripheral tissues.

Glutamine Synthetase

• Detoxifies ammonia in peripheral tissues (especially brain and muscle) by combining glutamate + $NH_4^+$ → glutamine, consuming ATP
• Feedback inhibited by glutamine and several other nitrogen-containing end products (a form of cumulative feedback inhibition)
• Glutamine transports nitrogen safely through the blood to the liver (for urea synthesis) and kidney (for direct $NH_4^+$ excretion into urine, which also helps with acid-base balance)

Carbamoyl Phosphate Synthetase I (CPS-I)

• Commits nitrogen to the urea cycle by synthesizing carbamoyl phosphate from $NH_4^+$ + $HCO_3^-$ + 2 ATP in the mitochondrial matrix
• Absolutely requires N-acetylglutamate (NAG) as an allosteric activator. NAG is synthesized by N-acetylglutamate synthase, which is activated by arginine. So a high arginine level signals high amino acid catabolism and turns on the urea cycle. No NAG means no urea cycle activity.
• Don't confuse this with CPS-II, which is cytosolic, uses glutamine (not free $NH_4^+$) as its nitrogen source, and feeds into pyrimidine biosynthesis.

---

Quick Reference Table

---

Self-Check Questions

1. PFK-1 and pyruvate kinase are both inhibited by ATP. What does this tell you about how glycolysis responds to cellular energy status? Why is PFK-1 considered the more important regulatory point?

2. Explain how malonyl-CoA coordinates fatty acid synthesis and β-oxidation. Which enzymes does it affect, and what happens to malonyl-CoA levels during fasting vs. the fed state?

3. Compare the regulation of glycogen synthase and glycogen phosphorylase. How does phosphorylation affect each enzyme differently, and which hormones drive these changes?

4. A patient has a deficiency in glucose-6-phosphatase (Von Gierke disease). Predict the metabolic consequences, including effects on blood glucose, glycogen stores, and lactate levels. Why can't muscle compensate for this defect?

5. Both isocitrate dehydrogenase and α-ketoglutarate dehydrogenase are inhibited by NADH. Explain why the TCA cycle slows when the NADH/NAD⁺ ratio is high, and connect this to the rate of electron transport and oxidative phosphorylation.